$RCUS Cashflow Statement | Understand Stock

$RCUS

$18.14 +$0.38 (2.14%) Close

$RCUS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flow from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense
Depreciation and amortization
Noncash lease expense
Impairment on right-of use assets
Amortization of discounts on marketable securities
Effective interest on liability for sale of future royalties
Other items, net
Changes in operating assets and liabilities:
Receivable from collaboration partners ($6, $14 and $19 from a related party)
Prepaid expenses and other current assets
Other assets ($—, $6 and ($4) from a related party)
Accounts payable ($24, $—, and $— to a related party)
Accrued research and development
Other accrued liabilities
Deferred revenue (($240), ($56) and ($77) to a related party)
Operating lease liabilities
Other liabilities

Net cash used in operating activities
Cash flow from investing activities
Purchases of short-term and long-term investments
Proceeds from maturities of short-term and long-term investments
Sales of short-term and long-term investments
Purchases of marketable securities
Proceeds from maturities of marketable securities
Proceeds from sales of marketable securities
Purchases of property and equipment
Purchases of in-process research and development
Collaboration reimbursements of in-process research and development from a related party
Other items, net
Net cash provided by (used in) investing activities

Cash flow from financing activities
Proceeds from issuance of common stock ($14, $228 and $20 from a related party), net
Proceeds from debt issuances, net
Proceeds from issuance of common stock pursuant to equity award plans
Repurchase of unvested shares of stock
Payments of employee taxes related to net settlement of equity awards
Proceeds from sale of future royalties
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Supplemental disclosure of cash flow information
Income taxes paid
Interest paid
Non-cash investing and financing activities:
Unpaid portion of property and equipment purchases included in Accounts payable and Other current liabilities
Unpaid portion of other assets included in accrued research and development

Comments